DAYVIGO
Active substance: lemborexant
TABLET, FILM COATED · LEMBOREXANT 5 mg/1
United StatesActive
Marketing holder: Eisai Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- LEMBOREXANT · 5 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-ef93-74ed-9560-8a2ea22a1f36;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a12092-2422-7789-aac1-59a4878c39c6,01a12096-add5-764e-b67f-94cad5cab107;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 62856-405
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
Sources
- product · openFDA NDC · 62856-405 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 62856-405 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 62856-405 · Verified 2026-10-09 · open in source